Daratumumab
Daratumumab is a drug used to treat Multiple Myeloma, Plasma Cell Myeloma, Myeloma, and other conditions. Daratumumab is being actively studied in 118 studies and prior, has been studied in 20.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Janssen Research & Development, LLC | Colorado Blood Cancer Institute | Fernando Fervenza |
| Mayo Clinic | Mayo Clinic | Ajai Chari |
| Celgene | Hosp. Clinico Univ. de Salamanca | Ajay Nooka |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Multiple Myeloma
- Daratumumab
- Cologne, GermanyUniversity of Cologne
2022-04-04
Apr 4, 2022S
Withdrawn
- Multiple Myeloma
- Daratumumab
- Charlotte, North CarolinaLevine Cancer Institute
2022-03-25
Mar 25, 2022J
Recruiting
- Chronic Lymphocytic Leukemia
- Daratumumab
- +3 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2022-02-24
Feb 24, 2022C
Completed
- Multiple Myeloma
- Ciforadenant
- daratumumab
- Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-03-09
Mar 9, 2022A
Not yet recruiting
- Plasma Cell Leukemia
- Daratumumab
- (no location specified)
2021-09-22
Sep 22, 2021T
Recruiting
- Multiple Myeloma
- Lenalidomide Pill
- +2 more
- Indianapolis, IndianaVA Roudebush Medical Center
2022-01-27
Jan 27, 2022M
Active, not recruiting
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
- Jacksonville, FloridaMayo Clinic in Florida
2022-03-25
Mar 25, 2022W
Not yet recruiting
- Glioblastoma
- Daratumumab
- Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
2021-06-25
Jun 25, 2021W
Recruiting
- Waldenstrom Macroglobulinemia
- +6 more
- Ibrutinib
- Daratumumab
- New York, New YorkWeill Cornell Medicine
2021-12-21
Dec 21, 2021M
Recruiting
- Lupus Nephritis
- Daratumumab
- Rochester, MinnesotaMayo Clinic in Rochester
2021-05-19
May 19, 2021F
Completed
- Membranoproliferative Glomerulonephritis
- Daratumumab
- Rochester, MinnesotaMayo Clinic
2021-06-28
Jun 28, 2021W
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +3 more
- New York, New YorkWeill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021P
Recruiting
- Amyloidosis; Systemic
- Daratumumab
- +2 more
- Beijing, ChinaPeking Union Medical College Hospital
2021-05-31
May 31, 2021M
Recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +4 more
- Daratumumab
- Ibrutinib
- Jacksonville, FloridaMayo Clinic in Florida
2022-03-22
Mar 22, 2022B
Completed
- AL Amyloidosis
- daratumumab
- Boston, MassachusettsBoston Medical Center
2021-04-15
Apr 15, 2021G
Recruiting
- Multiple Myeloma
- XmAb24306
- Daratumumab
- Melbourne, Victoria, AustraliaAlfred Hospital
2022-03-15
Mar 15, 2022T
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Daratumumab
- (no location specified)
2021-10-10
Oct 10, 2021H
Recruiting
- Multiple Myeloma
- Daratumumab
- +3 more
- Hackensack, New JerseyJohn Theurer Cancer Center
2022-03-04
Mar 4, 2022C
Completed
- Multiple Myeloma in Relapse
- Daratumumab
- Kingston, Ontario, Canada
- +5 more
2022-02-14
Feb 14, 2022M
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Daratumumab
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022W
Recruiting
- Amyloid
- +2 more
- Daratumumab
- +2 more
- Palo Alto, California
- +3 more
2021-06-23
Jun 23, 2021H
Recruiting
- Multiple Myeloma
- Selinexor 60 MG
- +6 more
- Washington, District of Columbia
- +1 more
2022-02-03
Feb 3, 2022U
Completed
- Amyloidosis
- Daratumumab
- Angers, France
- +9 more
2021-07-08
Jul 8, 2021C
Recruiting
- Plasma Cell Myeloma
- Secondary Amyloidosis
- Autologous Hematopoietic Stem Cell Transplantation
- +3 more
- Duarte, California
- +1 more
2021-12-27
Dec 27, 2021D
Active, not recruiting
- Waldenström Macroglobulinemia
- Daratumumab
- Boston, Massachusetts
- +4 more
2021-04-21
Apr 21, 2021